SCHEMBL22145128

SCHEMBL22145128

COc1ccc(C2(c3ccc(OC)cc3)C=Cc3c(c4ccccc4c4c5ccccc5n(C)c34)O2)cc1

nearest known ligand 0.40

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
KDM4E B2RXH2 6/20 0.38
HPGD P15428 3/20 0.38
ALDH1A1 P00352 3/20 0.38
L3MBTL1 Q9Y468 3/20 0.38
HTT P42858 2/20 0.38
HSD17B10 Q99714 2/20 0.38
MAPT P10636 2/20 0.38
MEN1 O00255 1/20 0.38
KMT2A Q03164 1/20 0.38
BCHE P06276 1/20 0.36
ACHE P22303 1/20 0.36
CYP1A2 P05177 1/20 0.35
CYP3A4 P08684 1/20 0.35
CYP2C19 P33261 1/20 0.35
MYLK Q15746 4/20 0.35
GAA P10253 3/20 0.35
USP2 O75604 1/20 0.35
TSHR P16473 1/20 0.35
PABPC1 P11940 1/20 0.34
ALOX15 P16050 1/20 0.34

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL22145138 0.89 KDM4E (0.38) KDM4EHPGDALDH1A1HSD17B10MAPT
SCHEMBL22145201 0.87 MAPT (0.36) KDM4EHPGDALDH1A1HTTHSD17B10
SCHEMBL22145205 0.86 EDNRA (0.34) KDM4EHPGDALDH1A1L3MBTL1HTT
SCHEMBL22145135 0.84 EDNRA (0.36) KDM4EHPGDALDH1A1MAPTMEN1
SCHEMBL22145207 0.84 KDM4E (0.33) KDM4EHPGDALDH1A1L3MBTL1HTT
SCHEMBL22145210 0.83 ALDH1A1 (0.31) KDM4EHPGDALDH1A1HTTHSD17B10
SCHEMBL22145211 0.81 POLB (0.31) MAPTPOLB
SCHEMBL22145126 0.81 PPARG (0.38) HPGDALDH1A1L3MBTL1MAPTPOLB
SCHEMBL22145250 0.80 KDM4E (0.36) KDM4EHPGDALDH1A1L3MBTL1HTT
SCHEMBL22145204 0.80 L3MBTL1 (0.31) KDM4EHPGDALDH1A1L3MBTL1HTT

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 5 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-3898636-B9 INDOLONAPHTHOPYRANS TRANSITIONS OPTICAL LTD (IE) 2023-11-08 EP disclosed
EP-3898636-B1 INDOLONAPHTHOPYRANS TRANSITIONS OPTICAL LTD (IE) 2023-08-30 EP disclosed
US-20220056039-A1 Indolonaphthopyrans TRANSITIONS OPTICAL, LTD. (IE) 2022-02-24 US disclosed
US-20210317129-A1 Indolenaphthopyrans TRANSITIONS OPTICAL, LTD. (IE) 2021-10-14 US disclosed
WO-2020126032-A1 INDOLONAPHTHOPYRANS TRANSITIONS OPTICAL, LTD. (IE) 2020-06-25 WO disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20210317129-A1 Indolenaphthopyrans AHR, TDO2, TPH2 KDM4E 3276/4885HPGD 2147/4885ALDH1A1 953/4885
US-20220056039-A1 Indolonaphthopyrans TPH1, TPH2, IDO1 KDM4E 3356/4885HPGD 1161/4885ALDH1A1 230/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.